S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
North Dakota tribe buys idle oil pipeline from Enbridge
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
NYSEARCA:JVAL

JPMorgan US Value Factor ETF (JVAL) Price, Holdings, & News

$34.93
-0.03 (-0.09%)
(As of 06/9/2023 ET)
Compare
Today's Range
$34.85
▼
$35.08
50-Day Range
$32.82
▼
$34.96
52-Week Range
$29.49
▼
$36.49
Volume
32,054 shs
Average Volume
247,803 shs
Market Capitalization
$852.29 million
Assets Under Management
$535.85 million
Dividend Yield
2.32%
Net Expense Ratio
0.12%
ProfileChartHeadlinesHoldings
JVAL stock logo

About JPMorgan US Value Factor ETF (NYSEARCA:JVAL)

The JPMorgan U.S. Value Factor ETF (JVAL) is an exchange-traded fund that is based on the JP Morgan US Value Factor index. The fund tracks an index of large-cap US equities that are selected and weighted by four relative valuation factors: book yield, earnings yield, dividend yield and cash flow yield. JVAL was launched on Nov 8, 2017 and is managed by JPMorgan Chase.

Receive JVAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JPMorgan US Value Factor ETF and its competitors with MarketBeat's FREE daily newsletter.

JVAL ETF News Headlines

May 30, 2023 | ft.com
JPMorgan’s US debt default Q&A
March 30, 2023 | morningstar.com
JPMorgan US Small Company R2
June 10, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
March 6, 2023 | bloomberg.com
JPMorgan Spells Out ‘Volmageddon’ Risk on Zero-Day Option Craze
February 28, 2023 | money.usnews.com
iShares Core S&P US Value ETF
February 5, 2023 | morningstar.com
JPMorgan US Small Company L
February 1, 2023 | cnbc.com
JPMorgan says Hong Kong shares to rebound in February and names 5 stocks to own
January 29, 2023 | seekingalpha.com
JPMorgan: Investors Are Worried About Its Capital Trajectory
June 10, 2023 | Behind the Markets (Ad)
"The $51 Billion Laser Revolution"
See how a new contract with the Pentagon could spark a 2,476% sales surge for a small laser firm >>>
November 23, 2022 | morningstar.com
JPMorgan US Small Company R6
See More Headlines

JVAL Price History

Fund Details

Issuer
JPMorgan
Fund Name
JPMorgan US Value Factor ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:JVAL
Inception Date
11/8/2017
Fund Manager
Yazann Romahi, Jonathan Msika, Joe Staines, Steven Yegang Wu, Aijaz Hussain
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
JP Morgan US Value Factor Index
Category
Broad Equity
Focus
Broad Equity
Development Level
Developed Markets
Region
North America
Number of Holdings
373

Fund Statistics

Assets Under Management
$536.51 million
Average Daily Volume
$457,303.10
Discount/Premium
1.08%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investment Management Inc.
Advisor
J.P. Morgan Investment Management Inc.
Custodian
JPMorgan Chase Bank, N.A.
Distributor
JPMorgan Distribution Services, Inc.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
2,100 shs

Miscellaneous

Outstanding Shares
24,400,000
Beta
1.05
Creation Unit
50,000
Creation Fee
$1,000.00


JPMorgan US Value Factor ETF Expenses

TypeJVALBroad Equity ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.12%0.48%0.52%0.50%0.50%
Other Expenses0.00%0.47%0.53%0.64%0.57%
Total Expense0.12%0.63%0.69%0.74%0.69%
Fee Waiver0.00%-0.50%-0.56%-0.70%-0.59%
Net Expense0.12%0.52%0.59%0.57%0.57%

JPMorgan US Value Factor ETF (JVAL) Holdings & Exposure

Top 10 JVAL Holdings

JVAL Sector Exposure

JVAL Industry Exposure

Full Holdings Details













JVAL ETF - Frequently Asked Questions

How have JVAL shares performed in 2023?

JPMorgan US Value Factor ETF's stock was trading at $33.14 on January 1st, 2023. Since then, JVAL shares have increased by 5.4% and is now trading at $34.93.
View the best growth stocks for 2023 here.

What does JVAL invest in?

JPMorgan US Value Factor ETF is a equity fund issued by JPMorgan. JVAL focuses on broad equity investments and follows the JP Morgan US Value Factor Index. The fund's investments total to approximately $536.51 million assets under management.

What stocks does JPMorgan US Value Factor ETF hold?

JVAL invests in 373 holdings. Some of the stocks in their portfolio include Meta Platforms (META), Alphabet (GOOGL), Microsoft (MSFT), Apple (AAPL), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Broadcom (AVGO), Pfizer (PFE) and Texas Instruments (TXN).

What is the management fee for JPMorgan US Value Factor ETF?

JPMorgan US Value Factor ETF's management fee is 0.12% and has no other recorded expenses or fee waivers. The net expense ratio for JVAL is 0.12%.

What is JPMorgan US Value Factor ETF's stock symbol?

JPMorgan US Value Factor ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "JVAL."

Who are JPMorgan US Value Factor ETF's major shareholders?

JPMorgan US Value Factor ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (44.89%), First Citizens Bank & Trust Co. (43.22%), Cobblestone Capital Advisors LLC NY (4.45%), LPL Financial LLC (2.44%), Cerity Partners LLC (2.24%) and Capital Analysts LLC (2.05%).

How do I buy shares of JPMorgan US Value Factor ETF?

Shares of JVAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is JPMorgan US Value Factor ETF's stock price today?

One share of JVAL stock can currently be purchased for approximately $34.93.

How much money does JPMorgan US Value Factor ETF make?

JPMorgan US Value Factor ETF (NYSEARCA:JVAL) has a market capitalization of $852.29 million.

This page (NYSEARCA:JVAL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -